This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

2-Adrenergic Receptor Function in Depression

The Cortisol Response to Yohimbine

Lawrence H. Price, MD; Dennis S. Charney, MD; A. Lawrence Rubin, MD; George R. Heninger, MD

Arch Gen Psychiatry. 1986;43(9):849-858.

Abstract
• There is evidence that the abnormalities in hypothalamicpituitary-adrenal (HPA) axis function observed in patients with depression may be related to changes in central neurotransmitter receptor function. To evaluate this possibility further, the ₂-adrenergic receptor antagonist yohimbine hydrochloride, which increases brain norepinephrine turnover, was administered to 40 patients with DSM-III major depression (18 melancholic, 22 nonmelancholic) and 16 healthy controls. Plasma free 3-methoxy-4-hydroxyphenylglycol (MHPG) level was measured as an index of noradrenergic function, and plasma cortisol level was used to assess the HPA response. Baseline cortisol levels were elevated in melancholic depressed patients, but not in nonmelancholic patients, when compared with healthy controls. The cortisol response to yohimbine was significantly greater in depressed patients than in controls, despite similar MHPG responses between groups. Since there is evidence that stimulation of postsynaptic ₂-adrenergic receptors inhibits HPA axis function, the abnormally increased cortisol response to the ₂-antagonist yohimbine suggests a relative subsensitivity of postsynaptic ₂-adrenergic receptors in depression.

Author Affiliations
From the Clinical Neuroscience Research Unit, Ribicoff Research Facilities, Connecticut Mental Health Center, and the Department of Psychiatry, Yale University School of Medicine, New Haven. Dr Rubin is now with Falkirk Hospital, Central Valley, NY.

Footnotes
Accepted for publication Nov 22, 1985.

Reprint requests to Department of Psychiatry, Yale University School of Medicine, 34 Park St, New Haven, CT 06508 (Dr Price).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Reduced Clonidine Rapid Eye Movement Sleep Suppression in Patients With Primary Major Affective Illness
Schittecatte et al.
Arch Gen Psychiatry 1992;49:637-642.
ABSTRACT  

Acute and chronic idazoxan in normal volunteers: biochemical, physiological and psychological effects
Glue et al.
J Psychopharmacol 1991;5:396-403.
ABSTRACT